Skip to main content
Money Brief
Money Brief21 September 2026

Global Market Pulse: Banking Caution, Tech Innovation, and Shifting Index Landscapes

This week’s global market brief highlights Bank of America's cautious outlook amid Fed rate hikes, innovative strides in autonomous aviation, and notable index adjustments affecting major tech and defense firms.

  • markets
  • earnings
  • technology
  • energy
  • healthcare
  • corporate governance

Banking Sector Faces Investor Unease

Bank of America (BAC) experienced a notable stock decline of nearly 8% last week following CEO Brian Moynihan’s remarks at the Barclays Financial Services Conference. Moynihan projected a more than 10% year-over-year drop in third-quarter investment banking fees, which, combined with the Federal Reserve’s recent rate hike—the first since 2023—raised investor concerns about near-term revenue streams. Despite this, analysts maintain confidence in BAC’s long-term value, with TIKR’s valuation model anticipating a substantial return by 2030, attributing the dip to a temporary fee mix issue rather than a fundamental earnings shift (Yahoo Finance).

Energy Sector Earnings Outlook Brightens

In the energy sector, Evergy has seen upward revisions in earnings forecasts. Zacks Research increased its Q1 2027 EPS estimate to $0.71, with full-year projections for 2027 and 2028 at $4.59 and $4.92 per share, respectively. Evergy recently exceeded expectations with a Q1 EPS of $0.88 and revenue of $1.5 billion, supporting a "Moderate Buy" consensus and an attractive quarterly dividend yielding approximately 3.5% annually (MarketBeat). Meanwhile, Enbridge received a "Strong-Buy" rating from Scotiabank, with FY2026 and FY2027 EPS estimates of $2.11 and $2.34, respectively. The company also boasts a robust annualized dividend yield near 8%, underpinned by strong Q2 earnings results (MarketBeat).

Innovation in Autonomous Aviation

Textron Aviation, in partnership with autonomous flight software firm Merlin, unveiled the Cessna SkyCourier UX—a pilotless cargo plane concept aimed at bridging the gap between small drones and large military airlifters. This initiative leverages an existing certified aircraft enhanced with autonomous technology to potentially transform military logistics. However, the project remains exploratory with no confirmed orders or delivery timelines, and Textron Aviation’s recent mixed financial performance tempers immediate expectations (Yahoo Finance).

Consumer Tech and Extended Device Lifecycles

Assurant (AIZ) is capitalizing on a trend of consumers holding onto iPhones longer, with trade-in devices now averaging over four years old. This shift has driven a 21% increase in adjusted EBITDA within Assurant’s Global Lifestyle segment, prompting a raised full-year outlook. While some growth derives from favorable reserve releases and lower catastrophe losses, the company’s position in device repair and resale markets appears strengthened in the evolving consumer tech landscape (Yahoo Finance).

Index Rebalancing Affects Key Technology and Defense Stocks

Recent FTSE All-World Index adjustments saw Aptiv PLC (APTV), an automotive technology firm, and Leidos Holdings (LDOS), a defense contractor, removed from the benchmark. Aptiv’s removal follows a significant year-to-date stock decline and multiple analyst downgrades, reflecting shifting investor sentiment in automotive tech (MarketScreener). Leidos, despite the index exclusion, maintains positive analyst momentum with a recent "Outperform" rating and a substantial $875 million US Navy contract win, underscoring resilience amid market reclassification (MarketScreener).

Corporate Governance and Legal Developments

Shareholders of Black Rock Coffee Bar, Inc. (BRCB) are being encouraged by Bronstein, Gewirtz & Grossman, LLC to inquire about a securities investigation related to potential corporate wrongdoing. The firm seeks to assist investors who purchased shares prior to September 12, 2025, emphasizing accountability and capital recovery efforts (ACCESS Newswire).

Advancing Global Clinical Research

In the healthcare and biotech arena, National Taiwan University Hospital and Johnson & Johnson Taiwan have formalized a partnership to enhance multinational clinical trial opportunities. Their collaboration focuses on cancer, immune-mediated diseases, and advanced medical technologies, aiming to accelerate innovative drug development and scientific talent exchange in the region (Healthcare Asia Magazine).

Not financial advice. Iron Wealth digests summarize public market news for education only.